Disclosure 16397
Publication date:
Last updated:
Summary
| Issuer |
Wockhardt Bio AG |
| Reason for disclosing |
Capital increase
|
| Basis of calculation |
51’948’000 |
| Purchase positions |
49’600’000
(95.480%)
|
| Sale positions |
0
(0.000%)
|
| Date of origination of the reporting obligation |
18.09.2015
|
Group of shareholders: Gruppe Wockhardt Ltd, Mumbai, Indien
| Beneficial owners |
| Gruppe Wockhardt Ltd, Mumbai, Indien |
| Dr Habil Fakhruddin Khorakiwala, Mumbai, Indien |
| Type of understanding |
|
Shareholders agreement
|
| Direct shareholder(s) |
Representation of the group |
|
Dr Habil Fakhruddin Khorakiwala, Mumbai, Indien |
Purchase positions
Inhaberaktien
| Number |
Voting rights |
| 49’600’000 |
49’600’000 |
No voting rights at own discretion
